-
COVID-19 - resources and news
Let's get social - see Cochrane social media platforms and learn how you can earn Membership points
Cochrane Crowd - citizen scientist platform
Cochrane Early Career Professional group - upcoming events
Help - FAQs and ticketed support
Cochrane International Mobility Programme - virtual and in-person placements with...
21 செப்டம்பர் 2021
-
Join world leaders of evidence synthesis to learn lessons from COVID-19 and shape responses to future health emergencies.
Cochrane Convenes is an online event hosted by Cochrane, co-sponsored by WHO, and co-organised with COVID-END (COVID-19 Evidence Network to support Decision-making).
Drawing on experiences of the COVID-19 pandemic, the...
20 செப்டம்பர் 2021
-
What do we need to know to improve the lives of older people, their families, and their communities? Through an interactive and engaging discussion, this online event highlighted the importance of knowledge sharing across sectors, disciplines, and regions to work together to foster healthy ageing across the globe. The event also launched the...
20 செப்டம்பர் 2021
-
Cochrane is preparing a series of reviews to help decision makers with their response to COVID-19. Each Cochrane podcast offers a short summary of a recent Cochrane COVID-19 review from the authors themselves. They allow everyone from healthcare professionals to patients and families to hear the latest Cochrane evidence in under five minutes.
...
20 செப்டம்பர் 2021
-
A recently published Cochrane review explores what measures can be taken in long-term care facilities to prevent COVID-19 outbreaks.
Can non-medicinal measures prevent or reduce SARS-CoV-2 infections in long term care facilities?
Key messages
Non-medicinal measures (e.g. visiting restrictions or regular testing) may prevent...
15 செப்டம்பர் 2021
-
In this author interview with Stephanie Weibel and Maria Popp, we find out more about their Cochrane review, Ivermectin for treating and preventing COVID-19. The review currently has an Altmetric Attention Score of more than 7000, which makes it the most talked-about review in the history of the Cochrane Library.
Briefly, what is...
14 செப்டம்பர் 2021
-
Cochrane Convenes will bring together key thought leaders from around the world to discuss the COVID-19 evidence response and develop recommendations to help prepare for and respond to future global health emergencies.
In this interview, we talk to John Lavis, a member of the Cochrane Convenes steering group, about what he hopes will come out of...
13 செப்டம்பர் 2021
-
Would you choose a treatment option that might increase your risk of developing dementia?
Anticholinergic drugs (which can relax smooth muscle, increase heart rate, and reduce bodily secretions) are commonly used in clinical practice for the management of many conditions affecting older adults - for example for urinary incontinence and for...
9 செப்டம்பர் 2021
-
We chatted with Jen Ma of Gentle Facts about how art can help in communicating science and health evidence, the challenges involved, and her work to address these.
Can you tell us a bit about yourself and background?
My name is Jennifer Ma (I go by Jen). I am a researcher by training and did my PhD in the Stem Cell Bioengineering lab at the...
9 செப்டம்பர் 2021
-
'SARS‐CoV‐2‐neutralising monoclonal antibodies for treatment of COVID‐19' from Cochrane Haematology published today in the Cochrane Library.
Key messages
We do not know whether antibodies (the body’s natural defence against disease) made in a laboratory and all the same as one another (monoclonal) and designed to target COVID-19, are an...
2 செப்டம்பர் 2021
-
September is Polycystic Ovary Syndrome Awareness Month and is an excellent time to focus on the latest Cochrane evidence.
Polycystic ovary syndrome (PCOS) is a common condition affecting 8% to 13% of women in reproductive age. There are three main PCOS features
menstrual cycle problems, such as irregular periods or having no periods (meaning the...
1 செப்டம்பர் 2021
-
Cochrane are signing a collaboration licence agreement with NICE, the National Institute for Health and Care Excellence, the UK government’s guideline organization. Cochrane has a long-established relationship with the NHS and the National Institute for Health research (NIHR), and Cochrane Reviews are already used to inform NICE guidelines. The...
1 செப்டம்பர் 2021
-
The Governing Board voted unanimously to re-appoint Catherine Marshall for a second term as Co-Chair from September 2021 until September 2023. Catherine will continue to work alongside fellow Co-Chair, Tracey Howe.
The Governing Board is responsible for setting Cochrane's strategic direction and overseeing the work of the Chief...
24 ஆகஸ்ட் 2021
-
24 ஆகஸ்ட் 2021
-
Cochrane Library Special Collections provide a round-up of up-to-date Cochrane evidence on a specific topic. This Special Collection has been created to highlight evidence-based interventions to reduce stillbirth and improve care for families after stillbirth and in a subsequent pregnancy, identify women at increased risk of stillbirth, and...
24 ஆகஸ்ட் 2021
-
Cochrane is delighted to launch a Russian translation of MECIR (Methodological Expectations for Cochrane Intervention Reviews) from Cochrane Russia.
This is the third translation of Cochrane’s methods guidance since the launch of version 6 of the Cochrane Handbook for Systematic Reviews of Interventions (see this Cochrane Editorial for more...
23 ஆகஸ்ட் 2021
-
16 ஆகஸ்ட் 2021
-
Are corticosteroids (anti-inflammatory medicines) given orally or by injection an effective treatment for people with COVID-19?
Key messages
Corticosteroids (anti-inflammatory medicines) given orally or by injection (systemic) are probably effective treatments for people hospitalised with COVID-19. The authors don’t know whether they cause...
16 ஆகஸ்ட் 2021
-
What can individuals do, especially those with long-term breathing problems, to avoid the effects of air pollution?
This recently published Cochrane review explores this question, and we sat down with the lead author of the review to discuss the review findings.
Tell us about this Cochrane review…What did you find out?
The main thing that we...
9 ஆகஸ்ட் 2021
-
In this recently published Cochrane review, authors explored the effects of treating COVID-19 with remdesivir, an antiviral medication.
First author Kelly Ansems said "Based on the currently available evidence remdesivir probably has little or no effect on all-cause mortality at up to 28 days in hospitalised adults with SARS-CoV-2 infection. We...
5 ஆகஸ்ட் 2021
COVID-19 - resources and news Let's get social - see Cochrane social media platforms and learn how you can earn Membership points Cochrane Crowd - citizen scientist platform Cochrane Early Career Professional group - upcoming events Help - FAQs and ticketed support Cochrane International Mobility Programme - virtual and in-person placements with...21 செப்டம்பர் 2021
Join world leaders of evidence synthesis to learn lessons from COVID-19 and shape responses to future health emergencies. Cochrane Convenes is an online event hosted by Cochrane, co-sponsored by WHO, and co-organised with COVID-END (COVID-19 Evidence Network to support Decision-making). Drawing on experiences of the COVID-19 pandemic, the...20 செப்டம்பர் 2021
What do we need to know to improve the lives of older people, their families, and their communities? Through an interactive and engaging discussion, this online event highlighted the importance of knowledge sharing across sectors, disciplines, and regions to work together to foster healthy ageing across the globe. The event also launched the...20 செப்டம்பர் 2021
Cochrane is preparing a series of reviews to help decision makers with their response to COVID-19. Each Cochrane podcast offers a short summary of a recent Cochrane COVID-19 review from the authors themselves. They allow everyone from healthcare professionals to patients and families to hear the latest Cochrane evidence in under five minutes. ...20 செப்டம்பர் 2021
A recently published Cochrane review explores what measures can be taken in long-term care facilities to prevent COVID-19 outbreaks.
In this author interview with Stephanie Weibel and Maria Popp, we find out more about their Cochrane review, Ivermectin for treating and preventing COVID-19. The review currently has an Altmetric Attention Score of more than 7000, which makes it the most talked-about review in the history of the Cochrane Library.
Cochrane Convenes will bring together key thought leaders from around the world to discuss the COVID-19 evidence response and develop recommendations to help prepare for and respond to future global health emergencies. In this interview, we talk to John Lavis, a member of the Cochrane Convenes steering group, about what he hopes will come out of...13 செப்டம்பர் 2021
Would you choose a treatment option that might increase your risk of developing dementia? Anticholinergic drugs (which can relax smooth muscle, increase heart rate, and reduce bodily secretions) are commonly used in clinical practice for the management of many conditions affecting older adults - for example for urinary incontinence and for...9 செப்டம்பர் 2021
We chatted with Jen Ma of Gentle Facts about how art can help in communicating science and health evidence, the challenges involved, and her work to address these. Can you tell us a bit about yourself and background?
'SARS‐CoV‐2‐neutralising monoclonal antibodies for treatment of COVID‐19' from Cochrane Haematology published today in the Cochrane Library. Key messages We do not know whether antibodies (the body’s natural defence against disease) made in a laboratory and all the same as one another (monoclonal) and designed to target COVID-19, are an...2 செப்டம்பர் 2021
September is Polycystic Ovary Syndrome Awareness Month and is an excellent time to focus on the latest Cochrane evidence. Polycystic ovary syndrome (PCOS) is a common condition affecting 8% to 13% of women in reproductive age. There are three main PCOS features menstrual cycle problems, such as irregular periods or having no periods (meaning the...1 செப்டம்பர் 2021
Cochrane are signing a collaboration licence agreement with NICE, the National Institute for Health and Care Excellence, the UK government’s guideline organization. Cochrane has a long-established relationship with the NHS and the National Institute for Health research (NIHR), and Cochrane Reviews are already used to inform NICE guidelines. The...1 செப்டம்பர் 2021
The Governing Board voted unanimously to re-appoint Catherine Marshall for a second term as Co-Chair from September 2021 until September 2023. Catherine will continue to work alongside fellow Co-Chair, Tracey Howe.
24 ஆகஸ்ட் 2021
Cochrane Library Special Collections provide a round-up of up-to-date Cochrane evidence on a specific topic. This Special Collection has been created to highlight evidence-based interventions to reduce stillbirth and improve care for families after stillbirth and in a subsequent pregnancy, identify women at increased risk of stillbirth, and...24 ஆகஸ்ட் 2021
Cochrane is delighted to launch a Russian translation of MECIR (Methodological Expectations for Cochrane Intervention Reviews) from Cochrane Russia. This is the third translation of Cochrane’s methods guidance since the launch of version 6 of the Cochrane Handbook for Systematic Reviews of Interventions (see this Cochrane Editorial for more...23 ஆகஸ்ட் 2021
16 ஆகஸ்ட் 2021
Are corticosteroids (anti-inflammatory medicines) given orally or by injection an effective treatment for people with COVID-19? Key messages Corticosteroids (anti-inflammatory medicines) given orally or by injection (systemic) are probably effective treatments for people hospitalised with COVID-19. The authors don’t know whether they cause...16 ஆகஸ்ட் 2021
What can individuals do, especially those with long-term breathing problems, to avoid the effects of air pollution? This recently published Cochrane review explores this question, and we sat down with the lead author of the review to discuss the review findings. Tell us about this Cochrane review…What did you find out? The main thing that we...9 ஆகஸ்ட் 2021
In this recently published Cochrane review, authors explored the effects of treating COVID-19 with remdesivir, an antiviral medication. First author Kelly Ansems said "Based on the currently available evidence remdesivir probably has little or no effect on all-cause mortality at up to 28 days in hospitalised adults with SARS-CoV-2 infection. We...5 ஆகஸ்ட் 2021